{"id":46058,"date":"2026-04-24T17:02:39","date_gmt":"2026-04-24T15:02:39","guid":{"rendered":"https:\/\/semaxpolska.com\/?p=46058"},"modified":"2026-07-12T12:02:08","modified_gmt":"2026-07-12T10:02:08","slug":"ghk-cu-peptidu-blakusparadibas","status":"publish","type":"post","link":"https:\/\/bioevidencehub.com\/lv\/skutki-uboczne-peptydu-miedzi-ghk-cu\/","title":{"rendered":"Blaknes GHK-Cu (vara pept\u012bds) zin\u0101tniskos p\u0113t\u012bjumos"},"content":{"rendered":"

Zin\u0101tniskajos p\u0113t\u012bjumos zi\u0146ot\u0101s vara pept\u012bda (GHK-Cu) blakuspar\u0101d\u012bbas parasti ir minim\u0101las un visbie\u017e\u0101k aprobe\u017eojas ar viegl\u0101m viet\u0113j\u0101m reakcij\u0101m. Cilv\u0113kiem veiktajos p\u0113t\u012bjumos, kuros tika izmantoti lok\u0101li prepar\u0101ti, piem\u0113ram, \u0101das noveco\u0161an\u0101s vai br\u016b\u010du dz\u012b\u0161anas kontekst\u0101, vara pept\u012bds parasti tiek labi panesams. Da\u017ei dal\u012bbnieki zi\u0146oja par nelielu \u0101das kairin\u0101jumu, vieglu aps\u0101rtumu vai \u012bslaic\u012bgu jut\u012bgumu aplik\u0101cijas viet\u0101 (Pickart & Margolina, 2018; Reddy et al., 2012). \u0160ie simptomi parasti ir \u012bslaic\u012bgi un nepast\u0101v pie turpm\u0101kas lieto\u0161anas. Dz\u012bvnieku p\u0113t\u012bjumos un laboratorijas eksperimentos pie standarta p\u0113t\u012bjumu dev\u0101m netika nov\u0113rotas konsekventas sist\u0113miskas toksicit\u0101tes paz\u012bmes. Kopum\u0101 vara pept\u012bds bie\u017ei tiek raksturots k\u0101 savienojums ar labv\u0113l\u012bgu dro\u0161\u012bbas profilu, sal\u012bdzinot ar citiem biolo\u0123iski akt\u012bviem pept\u012bdiem.<\/p>\n

No meh\u0101nisk\u0101 skatupunkta zems blakuspar\u0101d\u012bbu bie\u017eums var\u0113tu b\u016bt saist\u012bts ar to, ka \u0161is pept\u012bds dab\u012bgi sastopams cilv\u0113ka organism\u0101. Tas atrodams \u0137erme\u0146a \u0161\u0137idrumos, piem\u0113ram, asins plazm\u0101 un siekal\u0101s, k\u0101 ar\u012b audos, t\u0101d\u0113j\u0101di samazinot im\u016bnreakciju vai toksicit\u0101tes risku. Turkl\u0101t vara pept\u012bds sp\u0113c\u012bgi saista varu, \u013caujot kontrol\u0113ti pieg\u0101d\u0101t to un ierobe\u017eot br\u012bv\u0101 vara uzkr\u0101\u0161anos, kas var\u0113tu izrais\u012bt oksidat\u012bvo stresu. Tom\u0113r j\u0101uzsver, ka liel\u0101k\u0101 da\u013ca dro\u0161\u012bbas datu n\u0101k no lok\u0101las lieto\u0161anas, nevis sist\u0113miskas iedarb\u012bbas. Vara pept\u012bds, ko izmanto p\u0113t\u012bjumos, ir pieejams pie t\u0101diem pieg\u0101d\u0101t\u0101jiem k\u0101 SemaxPolska. Nevienas nopietnas blakuspar\u0101d\u012bbas pa\u0161reiz\u0113jos p\u0113t\u012bjumos nenoz\u012bm\u0113 apstiprin\u0101tu ilgtermi\u0146a dro\u0161\u012bbu, \u012bpa\u0161i liel\u0101k\u0101s dev\u0101s vai lietojot sist\u0113miski.<\/p>\n

Vai vara pept\u012bds (GHK-Cu) tiek uzskat\u012bts par dro\u0161u kl\u012bniskajos p\u0113t\u012bjumos ar cilv\u0113kiem?<\/strong><\/h2>\n

Var\u0161avas pept\u012bds kopum\u0101 tiek uzskat\u012bts par dro\u0161u, balstoties uz pieejamiem kl\u012bniskiem un kosm\u0113tiskiem p\u0113t\u012bjumiem, \u012bpa\u0161i lietojot lok\u0101li. Tom\u0113r j\u0101atz\u012bm\u0113, ka visaptvero\u0161i dro\u0161\u012bbas dati par da\u017e\u0101d\u0101m ievad\u012b\u0161anas metod\u0113m joproj\u0101m ir ierobe\u017eoti. Kontrol\u0113ti p\u0113t\u012bjumi ar cilv\u0113kiem, tostarp par \u0101das noveco\u0161anos un br\u016b\u010du dz\u012b\u0161anu, nor\u0101da uz labu panesam\u012bbu un nopietnu nev\u0113lamu blakuspar\u0101d\u012bbu tr\u016bkumu. \u0160ie p\u0113t\u012bjumi, kas ietver regul\u0101ru lieto\u0161anu vair\u0101kas ned\u0113\u013cas, vienlaic\u012bgi par\u0101da \u0101das parametru uzlabo\u0161anos (Pickart & Margolina, 2018; Mulder et al., 1994), kas liecina par pie\u0146emamu \u012bstermi\u0146a dro\u0161\u012bbu dermatolo\u0123iskos lietojumos.<\/p>\n

Tom\u0113r liel\u0101k\u0101 da\u013ca datu n\u0101k no kosm\u0113tisk\u0101s vai lok\u0101l\u0101s lieto\u0161anas. Tr\u016bkst lielo, labi p\u0101rdom\u0101tu kl\u012bnisko p\u0113t\u012bjumu, kas nov\u0113rt\u0113tu ilgtermi\u0146a lieto\u0161anu, sist\u0113misku lieto\u0161anu vai ietekmi da\u017e\u0101d\u0101s popul\u0101cij\u0101s. Da\u017e\u0101s valst\u012bs vara pept\u012bds tiek klasific\u0113ts k\u0101 kosm\u0113tisk\u0101 sast\u0101vda\u013ca, nevis \u0101rstniec\u012bbas l\u012bdzeklis, kas atspogu\u013co pa\u0161reiz\u0113jo zin\u0101tnisko pier\u0101d\u012bjumu l\u012bmeni.<\/p>\n

No biolo\u0123isk\u0101 viedok\u013ca t\u0101 dabisk\u0101 kl\u0101tb\u016btne organism\u0101 un l\u012bdzdal\u012bba atjauno\u0161anas procesos atbalsta t\u0101 dro\u0161\u012bbas profilu. Tom\u0113r tas neaizst\u0101j turpm\u0101ku kl\u012bnisko p\u0113t\u012bjumu nepiecie\u0161am\u012bbu. P\u0113t\u012bjumos izmantotais vara pept\u012bds ir pieejams no pieg\u0101d\u0101t\u0101jiem, piem\u0113ram, SemaxPolska. Pa\u0161reiz\u0113jie dati nor\u0101da uz dro\u0161\u012bbu lok\u0101l\u0101 lieto\u0161an\u0101, bet neapstiprina piln\u012bgu kl\u012bnisko dro\u0161\u012bbu ilgsto\u0161\u0101 vai sist\u0113misk\u0101 lieto\u0161an\u0101.<\/p>\n

K\u0101di toksikolo\u0123iskie dati par vara pept\u012bdu (GHK-Cu) ir pieejami zin\u0101tniskaj\u0101 literat\u016br\u0101?<\/strong><\/h2>\n

Toksikolo\u0123iskie dati par vara pept\u012bdu liecina par zemu toksicit\u0101ti gan laboratorijas (in vitro), gan dz\u012bvnieku (in vivo) p\u0113t\u012bjumos. P\u0113t\u012bjumi nor\u0101da, ka vara pept\u012bds nerada negat\u012bvu ietekmi uz \u0161\u016bnu dz\u012bvotsp\u0113ju koncentr\u0101cij\u0101s, kas l\u012bdz\u012bgas t\u0101m, kas sastopamas biolo\u0123isk\u0101s sist\u0113m\u0101s. Da\u017eos p\u0113t\u012bjumos pat tika konstat\u0113ts, ka tas veicina \u0161\u016bnu atjauno\u0161anos un palielina antioksidantu aktivit\u0101ti (Gruchlik et al., 2012). Dz\u012bvnieku p\u0113t\u012bjumos, kas koncentr\u0113j\u0101s uz br\u016b\u010du dz\u012b\u0161anu, iekaisumu un audu atjauno\u0161anos, netika nov\u0113rota org\u0101nu boj\u0101jumi vai b\u016btiski sist\u0113miski efekti pie tipisk\u0101m p\u0113t\u012bjumu dev\u0101m (Ma et al., 2020; Park et al., 2016).<\/p>\n

Papildu \u0101das dro\u0161\u012bbas izmekl\u0113jumi liecina par zemu kairino\u0161u potenci\u0101lu pat atk\u0101rtoti lok\u0101li lietojot (Lima & Moraes, 2018). B\u016btisks faktors ir ar\u012b \u0101tra vielmai\u0146a un izdal\u012b\u0161an\u0101s no organisma, kas samazina uzkr\u0101\u0161an\u0101s risku.<\/p>\n

Mek\u0101nistisk\u0101 skat\u012bjum\u0101 vara pept\u012bds darbojas k\u0101 biolo\u0123isko procesu regulators, ietekm\u0113jot g\u0113nu ekspresiju un oksidat\u012bvo l\u012bdzsvaru, nevis izraisot sp\u0113c\u012bgu biolo\u0123isku reakciju augst\u0101s koncentr\u0101cij\u0101s, k\u0101 tas notiek ar da\u017e\u0101m viel\u0101m. Tas veicina t\u0101 zemo toksicit\u0101ti. Tom\u0113r j\u0101uzsver, ka liel\u0101k\u0101 da\u013ca toksikolo\u0123isko datu n\u0101k no prekl\u012bniskiem un \u012bstermi\u0146a p\u0113t\u012bjumiem. P\u0113t\u012bjumos izmantotais vara pept\u012bds ir pieejams pie t\u0101diem pieg\u0101d\u0101t\u0101jiem k\u0101 SemaxPolska. Pa\u0161reiz\u0113jie dati nav pietiekami, lai noteiktu dro\u0161us ekspoz\u012bcijas l\u012bme\u0146us vis\u0101m lieto\u0161anas metod\u0113m vai ilgtermi\u0146a lieto\u0161anai cilv\u0113kiem.<\/p>\n

Vai p\u0113t\u012bjumos ir zi\u0146ots par risku saist\u012bb\u0101 ar vara l\u012bdzsvara trauc\u0113jumiem?<\/strong><\/h2>\n

Lai gan p\u0113t\u012bjumos tika apsv\u0113rti iesp\u0113jamie riski, kas saist\u012bti ar vara nel\u012bdzsvaru, tom\u0113r eksperiment\u0101lie rezult\u0101ti pie standarta p\u0113t\u012bjumos izmantotajiem l\u012bme\u0146iem to stingri neapstiprina. Vara pept\u012bds (GHK-Cu) sp\u0113c\u012bgi saista varu un darbojas k\u0101 kontrol\u0113ts nes\u0113js, kas noz\u012bm\u0113, ka tas transport\u0113 to dro\u0161\u0101 veid\u0101, nevis palielina br\u012bvo vara jonu l\u012bmeni. Br\u012bvais var\u0161 var izrais\u012bt kait\u012bgas oksidat\u012bv\u0101s reakcijas, savuk\u0101rt vara pept\u012bds samazina \u0161o risku, uzturot varu stabil\u0101 un regul\u0113t\u0101 st\u0101vokl\u012b (Pickart et al., 2015).<\/p>\n

P\u0113t\u012bjumi par oksidat\u012bvo stresu liecina, ka vara pept\u012bds var pat samazin\u0101t \u0161\u016bnu boj\u0101jumus, atbalstot antioksidantu sist\u0113mas un regul\u0113jot g\u0113nus, kas saist\u012bti ar aizsardz\u012bbu pret oksidat\u012bvo stresu (Ma et al., 2020). Tom\u0113r past\u0101v teor\u0113tiskas ba\u017eas, ka \u013coti lielas devas vai neparasta uzkr\u0101\u0161an\u0101s var\u0113tu ietekm\u0113t vara dabisko l\u012bdzsvaru organism\u0101, \u012bpa\u0161i met\u0101lu l\u012bmenim jut\u012bg\u0101s sist\u0113m\u0101s.<\/p>\n

L\u012bdz \u0161im veiktie p\u0113t\u012bjumi nav par\u0101d\u012bju\u0161i viennoz\u012bm\u012bgus vara p\u0101rdoz\u0113\u0161anas gad\u012bjumus vai noz\u012bm\u012bgus nel\u012bdzsvarot\u012bbas gad\u012bjumus, kas saist\u012bti ar vara pept\u012bdu lieto\u0161anu standarta eksperiment\u0101los vai kosm\u0113tiskos apst\u0101k\u013cos. Tom\u0113r j\u0101patur pr\u0101t\u0101, ka liel\u0101k\u0101 da\u013ca p\u0113t\u012bjumu tiek veikti kontrol\u0113tos apst\u0101k\u013cos, ar sal\u012bdzino\u0161i zem\u0101m dev\u0101m un lok\u0101li, kas ierobe\u017eo rezult\u0101tu visp\u0101rin\u0101\u0161anas iesp\u0113jas.<\/p>\n

Mek\u0101nistisk\u0101 skat\u012bjum\u0101 vara pept\u012bds pal\u012bdz uztur\u0113t vara l\u012bdzsvaru, darbojoties k\u0101 regul\u0113ta transport\u0113\u0161anas sist\u0113ma. Tom\u0113r \u0161is l\u012bdzsvars ir atkar\u012bgs no t\u0101diem faktoriem k\u0101 deva, lieto\u0161anas veids un biolo\u0123iskais konteksts. P\u0113t\u012bjumos izmantotais vara pept\u012bds ir pieejams pie pieg\u0101d\u0101t\u0101jiem, piem\u0113ram, SemaxPolska. Neskatoties uz to, ka nav skaidru pier\u0101d\u012bjumu par vara l\u012bdzsvara trauc\u0113jumu risku, ilgsto\u0161as vai lielu devu visp\u0101r\u0113jas lieto\u0161anas ietekme nav piln\u012bb\u0101 zin\u0101ma un prasa turpm\u0101kus p\u0113t\u012bjumus.<\/p>\n

 <\/p>\n

Atsauces<\/h4>\n
    \n
  • Pickart, L., & Margolina, A. (2018). GHK-Cu pept\u012bda re\u0123enerat\u012bv\u0101s un aizsarg\u0101jo\u0161\u0101s darb\u012bbas jaun\u0101ko g\u0113nu datu gaism\u0101. International Journal of Molecular Sciences, 19<\/em>(7), 1987.<\/span><\/li>\n
  • Reddy, B. Y., Jow, T., & Hantash, B. M. (2012). Bioakt\u012bvie oligopept\u012bdi dermatolo\u0123ij\u0101: I da\u013ca. Eksperiment\u0101l\u0101 dermatolo\u0123ija, 21<\/em>(8), 563\u2013568.<\/span><\/li>\n
  • Mulder, G. D., Patt, L. M., Sanders, L., Rosenstock, J., Altman, M. I., Hanley, M. E., & Duncan, G. W. (1994). Diab\u0113ta slimnieku \u010d\u016blu dz\u012b\u0161anas uzlabo\u0161ana, lok\u0101li apstr\u0101d\u0101jot ar glicil-L-histidil-L-lic\u012bna vara. Br\u016b\u010du dz\u012b\u0161ana un atjauno\u0161an\u0101s, 2<\/em>(4), 259\u2013269.<\/span><\/li>\n
  • Gruchlik, A., Jurzak, M., Chodurek, E., & Dzierzewicz, Z. (2012). Gly-Gly-His, Gly-His-Lys un to vara komplek\u0161u ietekme uz TNF-\u03b1 atkar\u012bgu IL-6 sekr\u0113ciju norm\u0101los cilv\u0113ka dermas fibroblastos. Acta Poloniae Pharmaceutica, 69<\/em>(6), 1303\u20131309.<\/span><\/li>\n
  • Ma, W., Li, M., Ma, H., Li, W., Liu, L., Yin, Y., Zhou, X., & Hou, G. (2020). GHK-Cu aizsarg\u0101jo\u0161\u0101 iedarb\u012bba bleomic\u012bna izrais\u012btas plau\u0161u fibrozes gad\u012bjum\u0101, izmantojot antioksidat\u012bv\u0101 stresa un pretiekaisuma ce\u013cus. Zin\u0101tnes par dz\u012bv\u012bbu, 241<\/em>, 117139.<\/span><\/li>\n
  • Parks, J. R., L\u012b, H., Kims, S. I., & Jangs, S. R. (2016). Tripept\u012bds GHK-Cu komplekss mazina lipopolisahar\u012bdu izrais\u012btu ak\u016btu plau\u0161u boj\u0101jumu pel\u0113m. Oncotarget, 7<\/em>(37), 58405\u201358417.<\/span><\/li>\n
  • Lima, T. N., & Pedriali Moraes, C. A. (2018). Bioakt\u012bvie pept\u012bdi: Pielietojumi un noz\u012bme kosm\u0113tikas l\u012bdzek\u013cos. Kosm\u0113tika, 5<\/em>(2), 21.<\/span><\/li>\n
  • Pickart, L., Vasquez-Soltero, J. M., & Margolina, A. (2015). GHK-Cu var nov\u0113rst oksidat\u012bvo stresu \u0101d\u0101, regul\u0113jot varu un modific\u0113jot daudzu antioksidantu g\u0113nu ekspresiju. Kosm\u0113tika, 2<\/em>(3), 236\u2013247.<\/span><\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"

    Zi\u0146ot\u0101s vara pept\u012bda (GHK-Cu) blakuspar\u0101d\u012bbas zin\u0101tniskajos p\u0113t\u012bjumos parasti ir minim\u0101las un visbie\u017e\u0101k aprobe\u017eojas ar viegl\u0101m viet\u0113j\u0101m reakcij\u0101m. P\u0113t\u012bjumos ar cilv\u0113kiem,\u2026.<\/p>","protected":false},"author":7908,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"footnotes":""},"categories":[93],"tags":[],"class_list":["post-46058","post","type-post","status-publish","format-standard","hentry","category-kategoria-ghk-cu","beh-no-thumb"],"_links":{"self":[{"href":"https:\/\/bioevidencehub.com\/lv\/wp-json\/wp\/v2\/posts\/46058","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bioevidencehub.com\/lv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bioevidencehub.com\/lv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bioevidencehub.com\/lv\/wp-json\/wp\/v2\/users\/7908"}],"replies":[{"embeddable":true,"href":"https:\/\/bioevidencehub.com\/lv\/wp-json\/wp\/v2\/comments?post=46058"}],"version-history":[{"count":0,"href":"https:\/\/bioevidencehub.com\/lv\/wp-json\/wp\/v2\/posts\/46058\/revisions"}],"wp:attachment":[{"href":"https:\/\/bioevidencehub.com\/lv\/wp-json\/wp\/v2\/media?parent=46058"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bioevidencehub.com\/lv\/wp-json\/wp\/v2\/categories?post=46058"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bioevidencehub.com\/lv\/wp-json\/wp\/v2\/tags?post=46058"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}